Analysts Set Smith & Nephew plc (LON:SN) PT at GBX 1,381.33

Posted by on Mar 27th, 2026

Smith & Nephew plc (LON:SN – Get Free Report) has been given a consensus recommendation of “Hold” by the six ratings firms that are covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is GBX 1,381.33.

Several equities analysts have recently issued reports on SN shares. Berenberg Bank reiterated a “hold” rating and set a GBX 1,300 price target on shares of Smith & Nephew in a research report on Friday, January 23rd. Panmure Gordon restated a “hold” rating and issued a GBX 1,200 price objective on shares of Smith & Nephew in a report on Tuesday, December 9th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 1,350 target price on shares of Smith & Nephew in a research note on Tuesday, March 17th.

View Our Latest Research Report on Smith & Nephew

Smith & Nephew Price Performance

Shares of LON:SN opened at GBX 1,195.50 on Wednesday. The company has a market capitalization of £13.11 billion, a PE ratio of 43.04, a price-to-earnings-growth ratio of 0.46 and a beta of 0.68. The company has a debt-to-equity ratio of 62.90, a quick ratio of 0.84 and a current ratio of 2.57. The business’s 50 day moving average price is GBX 1,268.09 and its 200 day moving average price is GBX 1,286.89.

Smith & Nephew Company Profile

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Read More

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.